Nitric oxide synthases and cardiovascular diseases - Insights from genetically modified mice

Masato Tsutsui, Hiroaki Shimokawa, Yutaka Otsuji, Yoichi Ueta, Yasuyuki Sasaguri, Nobuyuki Yanagihara

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

Nitric oxide (NO) is produced in almost all tissues and organs, exerting a variety of biological actions under both physiological and pathological conditions. NO is synthesized by 3 distinct NO synthase (NOS) isoforms (neuronal, inducible, and endothelial NOS), all of which are expressed in the human cardiovascular system. The regulatory roles of NOSs in cardiovascular diseases have been described in pharmacological studies with selective and non-selective NOS inhibitors. However, the specificity of the NOS inhibitors continues to be an issue of debate. To overcome this issue, genetically engineered animals have been used. All types of NOS gene-deficient (knockout: KO) animals, including singly, doubly, and triply NOS-KO mice, and various types of NOS gene-transgenic (TG) animals, including conditional and non-conditional TG mice bearing endothelium-specific or cardiomyocyte-specific overexpression of each NOS gene, have thus far been developed. The roles of individual NOS isoforms, as well as the entire NOS system, in the cardiovascular system have been extensively investigated in those mice, and the results provide pivotal insights into the pathophysiology of NOSs in human cardiovascular diseases. Based on studies with murine NOS genetic models, this review summarizes the latest knowledge of NOSs and cardiovascular diseases.

Original languageEnglish
Pages (from-to)986-993
Number of pages8
JournalCirculation Journal
Volume73
Issue number6
DOIs
Publication statusPublished - 2009 Jun

Keywords

  • Cardiovascular diseases
  • Knockout mice
  • Nitric oxide
  • Nitric oxide synthase
  • Transgenic mice

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Nitric oxide synthases and cardiovascular diseases - Insights from genetically modified mice'. Together they form a unique fingerprint.

  • Cite this

    Tsutsui, M., Shimokawa, H., Otsuji, Y., Ueta, Y., Sasaguri, Y., & Yanagihara, N. (2009). Nitric oxide synthases and cardiovascular diseases - Insights from genetically modified mice. Circulation Journal, 73(6), 986-993. https://doi.org/10.1253/circj.CJ-09-0208